IP Library › Granted Patent US 10,960,152
Granted Patent B2
US 10,960,152 · App. 16/064,177 · Granted Mar 30, 2021

Nicotine particle capsule

Inventors: Gerard Zuber (Froideville, CH); Nicolo Volpe (Lausanne, CH)
Assignee: Philip Morris Products S.A.
A61M15/0035A61K31/465A61K47/183A61M15/003A61M15/0021A61M15/06A24F47/002A61M2202/064
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,960,152
App. No.
16/064,177
Granted
Mar 30, 2021
Kind
B2
Abstract

A capsule containing particles including nicotine wherein a single aperture extends through the capsule.

Claims (19)

1. A capsule containing particles comprising nicotine salt and having a mass median aerodynamic diameter from about 0.5 micrometers to about 4 micrometers, and particles comprising flavor and having a mass median aerodynamic diameter from 50 micrometers to 150 micrometers, the capsule defining an internal volume,

wherein only a single aperture having a diameter from about 0.5 mm to about 1.5 mm extends through the capsule and is sized to provide a fraction amount of the particles comprising nicotine salt and the particles comprising flavor, at conventional smoking regime air flow rates of less than about 5 L/min once a piercing element used to form the single aperture is withdrawn from the single aperture.

2. The capsule according to claim 1 , wherein the ratio of the diameter of the single aperture to the mass median aerodynamic diameter of the particles comprising nicotine is from about 200 to about 800.

3. The capsule according to claim 1 , wherein the particles comprising nicotine salt comprise an amino acid.

4. The capsule according to claim 1 , wherein the single aperture has an open surface area of from about 0.2 mm 2 to about 1 mm 2 .

5. The capsule according to claim 1 , wherein the internal volume of the capsule is from about 0.2 ml to about 0.45 ml.

6. The capsule according to claim 1 , wherein the single aperture has an open surface area in a range from about 0.7 mm 2 to about 7 mm 2 per ml of internal volume of the capsule.

7. The capsule according to claim 1 , wherein the capsule contains from about 10 mg to about 200 mg of dry powder.

8. The capsule according to claim 1 , wherein the single aperture is incident with a longitudinal axis of the capsule.

9. A dry powder inhaler comprising a capsule according to claim 1 .

10. The dry powder inhaler according to claim 9 , wherein the capsule is disposed in a capsule cavity configured to allow the capsule to rotate with stability within the capsule cavity.

11. The capsule according to claim 1 , wherein the particles comprising nicotine comprise leucine or L-leucine.

12. The capsule according to claim 2 , wherein the particles comprising nicotine comprise leucine or L-leucine.

13. The capsule according to claim 1 , wherein the nicotine comprises nicotine salt comprises nicotine pyruvate, nicotine citrate, nicotine aspartate, nicotine lactate, nicotine bitartrate, nicotine salicylate, nicotine fumarate, nicotine monopyruvate, or nicotine glutamate.

14. A dry powder inhaler comprising a capsule according to claim 12 .

15. A capsule containing particles comprising nicotine salt and particles comprising flavor, the capsule defining an internal volume,

wherein only a single aperture extends through the capsule and is sized to provide a fraction amount of the particles comprising nicotine salt and the particles comprising flavor during an inhalation at conventional smoking regime air flow rates of less than about 5 L/min once a piercing element used to form the single aperture is withdrawn from the single aperture, the capsule providing from 5 to 10 inhalations of 0.1 mg to 3 mg nicotine particles per inhalation,

the particles comprising nicotine having a mass median aerodynamic diameter from about 0.5 micrometers to about 4 micrometers and the particles comprising flavor having a mass median aerodynamic diameter from 50 micrometers to 150 micrometers.

16. The capsule of claim 15 , wherein the nicotine salt comprises nicotine pyruvate, nicotine citrate, nicotine aspartate, nicotine lactate, nicotine bitartrate, nicotine salicylate, nicotine fumarate, nicotine monopyruvate, or nicotine glutamate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2019
From: ZUBER, GERARD; VOLPE, NICOLO
To: PHILIP MORRIS PRODUCTS S.A.
Reel/Frame 048128/0403 →
Priority Claims (2)
EP 15202712 · Dec 24, 2015 · regional
EP 16201580 · Nov 30, 2016 · regional
Continuity (1)
Related Publication 20190001084A1 · Jan 3, 2019